SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-19-004679
Filing Date
2019-03-22
Accepted
2019-03-22 16:30:32
Documents
8
Period of Report
2019-03-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER f6k0319_kitovpharma.htm 6-K 16325
2 PROXY STATEMENT FOR APRIL 29, 2019 SPECIAL GENERAL MEETING OF THE SHAREHOLDERS O f6k0319ex99-1_kitovpharma.htm EX-99.1 1892701
3 GRAPHIC img_1.jpg GRAPHIC 16371
4 GRAPHIC img_2.jpg GRAPHIC 43373
5 GRAPHIC img_3.jpg GRAPHIC 70220
6 GRAPHIC img_4.jpg GRAPHIC 7634
7 GRAPHIC img_5.jpg GRAPHIC 7634
8 GRAPHIC img_6.jpg GRAPHIC 7634
  Complete submission text file 0001213900-19-004679.txt   2121529
Mailing Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101
Business Address ONE AZRIELI CENTER, ROUND TOWER 132 MENACHEM BEGIN ROAD TEL AVIV L3 6701101 97239333121
Kitov Pharma Ltd. (Filer) CIK: 0001614744 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 19700220
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1